NRx Pharmaceuticals Statistics
Total Valuation
NRXP has a market cap or net worth of $31.36 million. The enterprise value is $37.19 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, after market close.
Earnings Date | Mar 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NRXP has 12.06 million shares outstanding. The number of shares has increased by 32.95% in one year.
Current Share Class | 12.06M |
Shares Outstanding | 12.06M |
Shares Change (YoY) | +32.95% |
Shares Change (QoQ) | +4.34% |
Owned by Insiders (%) | 15.77% |
Owned by Institutions (%) | 8.72% |
Float | 9.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.20
Current Ratio | 0.20 |
Quick Ratio | 0.08 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -66.05 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -145.66% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 129.29% |
Revenue Per Employee | n/a |
Profits Per Employee | -$10.19M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.20% in the last 52 weeks. The beta is 1.12, so NRXP's price volatility has been higher than the market average.
Beta (5Y) | 1.12 |
52-Week Price Change | -45.20% |
50-Day Moving Average | 2.68 |
200-Day Moving Average | 2.26 |
Relative Strength Index (RSI) | 43.27 |
Average Volume (20 Days) | 502,353 |
Short Selling Information
The latest short interest is 1.03 million, so 8.56% of the outstanding shares have been sold short.
Short Interest | 1.03M |
Short Previous Month | 1.21M |
Short % of Shares Out | 8.56% |
Short % of Float | 11.26% |
Short Ratio (days to cover) | 0.38 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -20.48M |
Pretax Income | -25.64M |
Net Income | -20.39M |
EBITDA | -20.47M |
EBIT | -20.48M |
Earnings Per Share (EPS) | -$2.12 |
Full Income Statement Balance Sheet
The company has $1.65 million in cash and $6.04 million in debt, giving a net cash position of -$4.39 million or -$0.36 per share.
Cash & Cash Equivalents | 1.65M |
Total Debt | 6.04M |
Net Cash | -4.39M |
Net Cash Per Share | -$0.36 |
Equity (Book Value) | -18.82M |
Book Value Per Share | -1.66 |
Working Capital | -16.19M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$11.73 million and capital expenditures $1,000, giving a free cash flow of -$11.73 million.
Operating Cash Flow | -11.73M |
Capital Expenditures | 1,000 |
Free Cash Flow | -11.73M |
FCF Per Share | -$0.97 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NRXP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -32.95% |
Shareholder Yield | -32.95% |
Earnings Yield | -62.15% |
FCF Yield | -35.76% |
Analyst Forecast
The average price target for NRXP is $31.67, which is 1,118.08% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $31.67 |
Price Target Difference | 1,118.08% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on April 2, 2024. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Apr 2, 2024 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |